Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001137774-26-000056·Arcutis Biotherapeutics, Inc.
Schedule 13G ownership disclosure
Arcutis Biotherapeutics Inc
Common · CUSIP: 03969K108
Event date: 2025-12-31
- Filing-level shares
- 7,079,926.00
- Percent of class
- 5.7%
- PRUDENTIAL FINANCIAL INC
Shares: 7,079,926.00 · Class: 5.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001137774-26-000056
- Form type
- SCHEDULE 13G/A
- Filer
- Arcutis Biotherapeutics, Inc.
- CIK
- CIK 1787306
- Filed
- Feb 13, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership